1-20 of 304
Paolo Corradini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT

Silvia Montoto, Jurgen Kuball, Jarl E Mooyaart, Artak Ghandilyan, Dilyana Georgieva, Isabel Sánchez-Ortega, Chiara Bonini, Urban Novak, Dominik Schneidawind, Ibrahim Yakoub-Agha, Jakob Passweg, Sr., Nicolaus Kröger, Christian R Schultze-Florey, Barbara Dreta, Lucia Lopez Corral, Polina Stepensky, Paolo Corradini, Andrea Kuhnl, Stefania Bramanti, Carlos Solano, Ludovic Gabellier, Anja van Biezen, Annalisa Ruggeri, Bertram Glass, Christian Chabannon
Journal: Blood
Blood (2024) 144 (Supplement 1): 607.
https://doi.org/10.1182/blood-2024-200367
Published: 2024
Journal Articles

Consolidation Treatment with VRD Followed By Maintenance with Lenalidomide in Multiple Myeloma Improves Overall Survival: Long-Term Follow-up of the EMN02/HOVON95 Randomized Phase 3 Trial

Pieter Sonneveld, Meletios A. Dimopoulos, Meral Beksac, Bronno van der Holt, Francesca Gay, Heinz Ludwig, Sonja Zweegman, Vladimir Maisnar, Maria Teresa Petrucci, Paolo Corradini, Francesca Patriarca, Angelo Belotti, Micol Quaresima, Mariella Grasso, Massimo Offidani, Laura Paris, Anna Marina Liberati, Markus Hansson, Heleen Visser-Wisselaar, Giulia Fumero, Renato Zambello, Paula F Ypma, Anna Pascarella, Niels Frost Andersen, Alexandra Croockewit, Mario Boccadoro, Michele Cavo
Journal: Blood
Blood (2024) 144 (Supplement 1): 674.
https://doi.org/10.1182/blood-2024-197908
Published: 2024
Journal Articles

Glofitamab in Combination with Polatuzumab Vedotin Maintains Durable Responses and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Including High-Grade B-Cell Lymphoma (HGBCL): Extended Follow-up of a Phase Ib/II Study

Martin Hutchings, Anna Sureda Balari, Francesc Bosch, Thomas Stauffer Larsen, Paolo Corradini, Abraham Avigdor, María José Terol, Antonio Rueda Dominguez, Antonio Pinto, Alan P Skarbnik, Raul Cordoba, Judit Mészáros Joergensen, Pier Luigi Zinzani, Ronit Gurion, Neta Goldschmidt, Wilfred Leung, Donghang Li, James Relf, Maneesh Tandon, Gila Sellam, Giuseppe Gritti
Journal: Blood
Blood (2024) 144 (Supplement 1): 988.
https://doi.org/10.1182/blood-2024-194328
Published: 2024
Journal Articles

Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party

Imke E. Karsten, Norbert Schmitz, Mathilde Fekom, Laurence de Leval, Hervé Finel, Irma Khvedelidze, Won Seog Kim, Depei Wu, Montserrat Rovira, Fengrong WANG, Xiao-Jun Huang, Peter Dreger, Johan Maertens, Paolo Corradini, Grzegorz Helbig, Wolfgang Andreas Bethge, Larry Bacon, Jan Vydra, Aitana Balaguer Rosello, Matthias Stelljes, Georg Lenz, Alina Daniela Tanase, Anna Sureda Balari, Ali Bazarbachi, Bertram Glass
Journal: Blood
Blood (2024) 144 (Supplement 1): 399.
https://doi.org/10.1182/blood-2024-210100
Published: 2024
Journal Articles

Fixed-Duration Glofitamab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-up from a Pivotal Phase II Study

Michael J. Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Guillaume Cartron, Paolo Corradini, Nancy L. Bartlett, Gloria Iacoboni, Cyrus Khan, Mark S. Hertzberg, Lorenzo Falchi, Joshua Brody, Marek Trněný, Estefania Mulvihill, Aurelien Berthier, Alessia Bottos, James Relf, Fabiola Bene Tchaleu, Linda Lundberg, Martin Hutchings
Journal: Blood
Blood (2024) 144 (Supplement 1): 865.
https://doi.org/10.1182/blood-2024-194333
Published: 2024
Journal Articles

Comparative Effectiveness of Ciltacabtagene Autoleucel from the Cartitude-4 Trial Vs Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma - an Updated Overall Survival Analysis

Cyrille Touzeau, Brea Lipe, Abdullah Mohammad Khan, Binod Dhakal, Sandhya Nair, Jianming He, João Mendes, Seina Lee, Carolina Lonardi, Ana Slaughter, Nikoletta Lendvai, Jordan M. Schecter, Diana Chen, Man Zhao, Tzu-min Yeh, Xavier Leleu, Noemi Puig, Dominik Dytfeld, Elena Zamagni, Katja C. Weisel, Lionel Karlin, Michel Delforge, Paolo Corradini, Roberto Mina, Wilfried Roeloffzen, Surbhi Sidana
Journal: Blood
Blood (2024) 144 (Supplement 1): 7089.
https://doi.org/10.1182/blood-2024-205383
Published: 2024
Journal Articles

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Isatuximab, Carfilzomib and Dexamethasone in the Treatment of Patients with Lenalidomide-Refractory Multiple Myeloma with 1-3 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison

Roberto Mina, Paolo Corradini, Michele Cavo, Jesús F. San-Miguel, Leyla O. Shune, Abdullah Mohammad Khan, Surbhi Sidana, Xavier Leleu, Salomon Manier, Brea Lipe, Katja C. Weisel, Suzy van Sanden, Joris Diels, João Mendes, Seina Lee, Sandra Van Hoorenbeeck, Adrián Pons, Ana Slaughter, Nina Benachour, Carolina Lonardi, Arnab Ghosh, Nitin Patel, Erika Florendo, Joaquín Martínez-Lopez
Journal: Blood
Blood (2024) 144 (Supplement 1): 7088.
https://doi.org/10.1182/blood-2024-205189
Published: 2024
Journal Articles

Factors Predicting Short-Term Symptom Burden in Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy: A Real-World Study By the Gimema

Fabio Efficace, Francesca Bonifazi, Pier Luigi Zinzani, Ilaria Cutini, Annalisa Chiappella, Barbara Botto, Maria Chiara Tisi, Stefania Bramanti, Thomas Baldi, Francesca Tartaglia, Mirko Farina, Simone Ragaini, Massimiliano Gambella, Enrico Orciuolo, Massimo Martino, Maurizio Martelli, Claudio Cartoni, Paolo Corradini, Paola Fazi, Marco Vignetti, Alice Di Rocco
Journal: Blood
Blood (2024) 144 (Supplement 1): 7823.
https://doi.org/10.1182/blood-2024-199498
Published: 2024
Journal Articles

Outcomes of CAR T-Cells Therapy in High-Grade B-Cell Lymphomas Compared to Diffuse Large B-Cell Lymphomas: A Weighted Comparison Analysis from CAR-T SIE Study

Anna Dodero, Giusy Ceparano, Beatrice Casadei, Piera Angelillo, Stefania Bramanti, Maria Chiara Tisi, Silva Ljevar, Annalisa Chiappella, Barbara Botto, Ilaria Cutini, Patrizia Chiusolo, Anna Maria Barbui, Mirko Farina, Alice Di Rocco, Giovanni Grillo, Jacopo Olivieri, Mauro Krampera, Lucia Brunello, Anna Guidetti, Pier Luigi Zinzani, Cristiana Carniti, Paolo Corradini
Journal: Blood
Blood (2024) 144 (Supplement 1): 3131.
https://doi.org/10.1182/blood-2024-199720
Published: 2024
Journal Articles

Real-World Practice Patterns of Patient Management in the Peri-CAR T-Cell Therapy Setting for Patients with Mantle Cell Lymphoma: An International Survey on Behalf of the EBMT Lymphoma Working Party

Gloria Iacoboni, Pere Barba, Irma Khvedelidze, Maud Ngoya, Paolo Corradini, Pierre Sesques, Marion Subklewe, Maria Gomes Da Silva, Gilles Crochet, Jarosław Dybko, Izaskun Zeberio, Alejandro Martín García-Sancho, Tom van Meerten, Maeve O'Reilly, Bertram Glass, Ana Maria Sureda Balari, Peter Dreger, Olivier Hermine, Ali Bazarbachi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3656.
https://doi.org/10.1182/blood-2024-205389
Published: 2024
Journal Articles

Biomarker Correlates and Clinical Activity of Cevostamab in Patients (pts) with Triple-Class Refractory Multiple Myeloma (MM) Who Have Received ≥1 Prior B-Cell Maturation Antigen (BCMA)-Targeted Bispecific Antibody (BsAb): Results from the Phase I/II CAMMA 2 Study

Michel Delforge, Joshua Richter, Yael C. Cohen, Paolo Corradini, Douglas W Sborov, Alexander M. Lesokhin, Jesus G Berdeja, Moshe E Gatt, Laura Paris, Laura Rosinol Dachs, Hang Quach, Manisha Kanwar, Olivier Catalani, Paresh Sewpaul, Elisabeth Wassner-Fritsch, Ameet Mishra, Kerstin Trunzer, Shaji Kumar
Journal: Blood
Blood (2024) 144 (Supplement 1): 4732.
https://doi.org/10.1182/blood-2024-199519
Published: 2024
Journal Articles

Minimal Residual Disease Evaluation in the Context of V-Rbac, a Risk-Tailored Phase II Trial of the Fondazione Italiana Linfomi (FIL)

Riccardo Bomben, Daniela Drandi, Irene Della Starza, Clara Bono, Andrea Evangelista, Omar Perbellini, Tamara Bittolo, Elisa Genuardi, Massimo Degan, Simone Ragaini, Maria Chiara Tisi, Anna Merli, Francesca Quaglia, Alessandro Re, Claudia Castellino, Vittorio Ruggero Zilioli, Francesco Piazza, Paolo Corradini, Stefan Hohaus, Gerardo Musuraca, Francesca Gaia Rossi, Benedetta Puccini, Federica Cavallo, Filippo Ballerini, Luca Arcaini, Valter Gattei, Ilaria Del Giudice, Sara Galimberti, Carlo Visco, Simone Ferrero
Journal: Blood
Blood (2024) 144 (Supplement 1): 4362.
https://doi.org/10.1182/blood-2024-203004
Published: 2024
Journal Articles

Primary Results of the Health-Related Quality of Life (HRQoL) and Tolerability Assessments from the Phase I/II NP30179 Study of Glofitamab Monotherapy in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Emmanuel Bachy, Peter Trask, Franck Morschhauser, Paolo Corradini, Shang-Ju Wu, Nancy L. Bartlett, Estefania Mulvihill, Fabiola Bene Tchaleu, Linda Lundberg, Carmelo Carlo-Stella
Journal: Blood
Blood (2024) 144 (Supplement 1): 1726.
https://doi.org/10.1182/blood-2024-194337
Published: 2024
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Retrospective Multicenter Analysis on 285 Procedures Performed between 2000 and 2020

Corrado Tarella, Simona Sammassimo, Samuele Frassoni, Alida Dominietto, Raffaella Cerretti, Maria Caterina Micò, Rocco Pastano, Martina Pennisi, Chiara Ghiggi, Gottardo De Angelis, Alessandra Algarotti, Patrizia Chiusolo, Enrico Derenzini, Simona Sica, Paolo Corradini, Vincenzo Bagnardi, Emanuele Angelucci, Alessandro Rambaldi, William G Arcese, Anna Dodero, Andrea Bacigalupo
Journal: Blood
Blood (2024) 144 (Supplement 1): 2186.
https://doi.org/10.1182/blood-2024-194320
Published: 2024
Journal Articles

TP53 , CD36 Mutations and CDKN2A Loss Predict Poor Outcome in Mantle Cell Lymphoma: Molecular Analysis of the FIL V-Rbac Phase 2 Trial

Riccardo Moia, Maria Elena Carazzolo, Chiara Cosentino, Mohammad Almasri, Donatella Talotta, Valentina Tabanelli, Giovanna Motta, Federica Melle, Maria Vittoria Sacchi, Andrea Evangelista, Luca Cividini, Maria Chiara Tisi, Merli Anna, Stefano Fiori, Alessandro Re, Claudia Castellino, Vittorio Ruggero Zilioli, Francesco Piazza, Paolo Corradini, Stefan Hohaus, Gerardo Musuraca, Francesca Gaia Rossi, Benedetta Puccini, Federica Cavallo, Filippo Ballerini, Roberta Sciarra, Alice Di Rocco, Annalisa Arcari, Carola Boccomini, Francesco Merli, Guido Gini, Monica Tani, Riccardo Bruna, Vincenzo Pavone, Marco Ladetto, Sara Galimberti, Riccardo Bomben, Valter Gattei, Ilaria Del Giudice, Simone Ferrero, Stefano Pileri, Monica Balzarotti, Gianluca Gaidano, Carlo Visco
Journal: Blood
Blood (2024) 144 (Supplement 1): 1577.
https://doi.org/10.1182/blood-2024-198076
Published: 2024
Journal Articles

Longitudinal Monitoring of Circulating Tumor DNA to Predict Survival in Newly Diagnosed Peripheral T-Cell Lymphoma Patients

Cristiana Carniti, Sadhana Jonnalagadda, Giada Zanirato, Martina Magni, Eugenio Fardella, Claudia Castellino, Alessandro Re, Chiara Ghiggi, Filippo Ballerini, Rosanna Ciancia, Lorella Orsucci, Antonio Pinto, Sara Usai, Francesca Gaia Rossi, Annalisa Arcari, Fiorella Ilariucci, Vittorio Ruggero Zilioli, Leonardo Flenghi, Melania Celli, Fabio Benedetti, Caterina Patti, Caterina Plenteda, Manuela Zanni, Gerardo Musuraca, Riccardo Bruna, Luca Arcaini, Federica Cavallo, Annalisa Chiappella, Anna Dodero, Paolo Corradini
Journal: Blood
Blood (2024) 144 (Supplement 1): 1580.
https://doi.org/10.1182/blood-2024-201391
Published: 2024
Journal Articles

Glofitamab Induces High Response Rates and Durable Remissions in Patients (Pts) with Heavily Pretreated Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL), Including Those with a Poor Prognosis: Subgroup Results from a Phase I/II Study

Tycel J. Phillips, Marek Trněný, Carmelo Carlo-Stella, Jan Maciej Zaucha, Tomasz Wrobel, Fritz Offner, Michael J. Dickinson, Monica Tani, Michael Crump, Nancy L. Bartlett, Joaquín Martínez-Lopez, Paolo Corradini, Estefania Mulvihill, Alessia Bottos, Derrick Kaufman, James Relf, Fabiola Bene Tchaleu, Alexandra Bazeos, Linda Lundberg, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 1631.
https://doi.org/10.1182/blood-2024-200018
Published: 2024
Journal Articles

A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection

Monia Marchetti, Paolo Corradini, Luca Arcaini, Stefania Bramanti, Alice Di Rocco, Marco Ladetto, Stefano Luminari, Luigi Rigacci, Pier Luigi Zinzani
Journal: Blood
Blood (2024) 144 (Supplement 1): 2269.
https://doi.org/10.1182/blood-2024-198647
Published: 2024
Journal Articles

High Ferritin and C-Reactive Protein Levels Result in Poor Clinical Outcome in R/R Large B-Cell Lymphoma Patients Despite Significant Anti-CD19 CAR-T Cell In Vivo Expansion

Martina Magni, Sadhana Jonnalagadda, Giada Zanirato, Silva Ljevar, Francesca Bonifazi, Pier Luigi Zinzani, Ilaria Cutini, Maria Chiara Tisi, Barbara Botto, Domenico Russo, Giovanni Grillo, Massimo Martino, Mauro Krampera, Massimo Massaia, Patrizia Chiusolo, Luca Arcaini, Stefania Bramanti, Anna Dodero, Annalisa Chiappella, Paolo Corradini, Cristiana Carniti
Journal: Blood
Blood (2024) 144 (Supplement 1): 4786.
https://doi.org/10.1182/blood-2024-201399
Published: 2024
Journal Articles

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

Clinical Trials & Observations Brief Report
Mattia D’Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, Angelo Belotti, Sonia Morè, Paolo Corradini, Stefania Oliva, Antonio Ledda, Mariella Grasso, Vincenzo Pavone, Sonia Ronconi, Iolanda Donatella Vincelli, Stelvio Ballanti, Cristina Velluti, Claudia Cellini, Alessandro Gozzetti, Angelo D. Palmas, Barbara Gamberi, Katia Mancuso, Laura Paris, Renato Zambello, Maria Teresa Petrucci, Benedetto Bruno, Pellegrino Musto, Francesca Gay
Journal: Blood
Blood (2024) 143 (7): 592–596.
https://doi.org/10.1182/blood.2023022080
Published: 2024
Includes: Supplemental data